Pediatric cancer recurrence is a daunting reality for many families facing the challenges of childhood cancers such as gliomas.Recent advancements in AI predicting cancer relapse offer a glimmer of hope by demonstrating superior accuracy in assessing the risk of recurrence compared to traditional methods.